ImmunoGen: Q3 Earnings Snapshot

WALTHAM, Mass. (AP) _ ImmunoGen Inc. (IMGN) on Friday reported a loss of $77.8 million in its third quarter. The Waltham, Massachusetts-based compa...

November 11, 2022
3:20 AM

WALTHAM, Mass. (AP) _ ImmunoGen Inc. (IMGN) on Friday reported a loss of $77.8 million in its third quarter. The Waltham, Massachusetts-based company said it had a loss of 31 cents per share. The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share. The drug developer posted revenue of $15.4 million in the period, surpassing Street forecasts. Seven analysts surveyed by Zacks expected $11.